SBRA Quote, Financials, Valuation and Earnings

New Concept Energy, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of -51.28%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat New Concept Energy, Inc.'s return on equity of -1.7%.

Sabra Health Care REIT, Inc. has a consensus price target of $20.69, signalling upside risk potential of 8.06%. On the other hand New Concept Energy, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sabra Health Care REIT, Inc. has higher upside potential than New Concept Energy, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than New Concept Energy, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.677, which suggesting that the stock is 32.339% less volatile than S&P 500. In comparison New Concept Energy, Inc. has a beta of -0.032, suggesting its less volatile than the S&P 500 by 103.158%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.24%. New Concept Energy, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. New Concept Energy, Inc. pays out -- of its earnings as a dividend.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than New Concept Energy, Inc. quarterly revenues of $39K. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than New Concept Energy, Inc.'s net income of -$20K. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.44x while New Concept Energy, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.19x versus 25.66x for New Concept Energy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

InnSuites Hospitality Trust has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of -22.29%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat InnSuites Hospitality Trust's return on equity of -137.9%.

Sabra Health Care REIT, Inc. has a consensus price target of $20.69, signalling upside risk potential of 8.06%. On the other hand InnSuites Hospitality Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that Sabra Health Care REIT, Inc. has higher upside potential than InnSuites Hospitality Trust, analysts believe Sabra Health Care REIT, Inc. is more attractive than InnSuites Hospitality Trust.

Sabra Health Care REIT, Inc. has a beta of 0.677, which suggesting that the stock is 32.339% less volatile than S&P 500. In comparison InnSuites Hospitality Trust has a beta of -0.169, suggesting its less volatile than the S&P 500 by 116.86%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.24%. InnSuites Hospitality Trust offers a yield of 1.55% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. InnSuites Hospitality Trust pays out 12.79% of its earnings as a dividend. InnSuites Hospitality Trust's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Sabra Health Care REIT, Inc.'s is not.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than InnSuites Hospitality Trust quarterly revenues of $1.8M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than InnSuites Hospitality Trust's net income of -$401K. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.44x while InnSuites Hospitality Trust's PE ratio is 43.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.19x versus 1.52x for InnSuites Hospitality Trust. Usually stocks with elevated PS ratios are considered overvalued.

Pebblebrook Hotel Trust has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of -8.12%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Pebblebrook Hotel Trust's return on equity of -3.47%.

Sabra Health Care REIT, Inc. has a consensus price target of $20.69, signalling upside risk potential of 8.06%. On the other hand Pebblebrook Hotel Trust has an analysts' consensus of $12.62 which suggests that it could grow by 14.58%. Given that Pebblebrook Hotel Trust has higher upside potential than Sabra Health Care REIT, Inc., analysts believe Pebblebrook Hotel Trust is more attractive than Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.677, which suggesting that the stock is 32.339% less volatile than S&P 500. In comparison Pebblebrook Hotel Trust has a beta of 1.530, suggesting its more volatile than the S&P 500 by 53.005%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.24%. Pebblebrook Hotel Trust offers a yield of 0.36% to investors and pays a quarterly dividend of $0.01 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Pebblebrook Hotel Trust pays out 247847.62% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are smaller than Pebblebrook Hotel Trust quarterly revenues of $398.7M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than Pebblebrook Hotel Trust's net income of -$32.4M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.44x while Pebblebrook Hotel Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.19x versus 0.89x for Pebblebrook Hotel Trust. Usually stocks with elevated PS ratios are considered overvalued.

Ventas, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 4.61%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Ventas, Inc.'s return on equity of 2.14%.

Sabra Health Care REIT, Inc. has a consensus price target of $20.69, signalling upside risk potential of 8.06%. On the other hand Ventas, Inc. has an analysts' consensus of $83.35 which suggests that it could grow by 4.19%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Ventas, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than Ventas, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.677, which suggesting that the stock is 32.339% less volatile than S&P 500. In comparison Ventas, Inc. has a beta of 0.777, suggesting its less volatile than the S&P 500 by 22.343%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.24%. Ventas, Inc. offers a yield of 2.36% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Ventas, Inc. pays out 923.55% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are smaller than Ventas, Inc. quarterly revenues of $1.5B. Sabra Health Care REIT, Inc.'s net income of $22.5M is lower than Ventas, Inc.'s net income of $68.7M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.44x while Ventas, Inc.'s PE ratio is 151.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.19x versus 6.47x for Ventas, Inc.. Usually stocks with elevated PS ratios are considered overvalued.